Prelude climbs as FDA clears study for Incyte-partnered cancer candidate Feb 3, 2026 On the Move Comments Grandbrothers/iStock Editorial via Getty Images Prelude Therapeutics (PRLD) traded higher on...
Incyte Japan gains approval for Minjuvi with rituximab and lenalidomide to treat relapsed follicular lymphoma Dec 22, 2025
